Suppr超能文献

链激酶对急性心肌梗死后再灌注及其并发症的影响:一项事后分析研究。

Effect of streptokinase on reperfusion after acute myocardial infarction and its complications: an ex-post facto study.

作者信息

Taheri Leila, Boroujeni Ali Zargham, Kargar Jahromi Marzieh, Charkhandaz Maryam, Hojat Mohsen

机构信息

Jahrom University of Medical Sciences, Jahrom, Iran.

出版信息

Glob J Health Sci. 2015 Jan 1;7(4):184-9. doi: 10.5539/gjhs.v7n4p184.

Abstract

INTRODUCTION

Emergency treatment of patients with acute myocardial infarction is very important. Streptokinase in Iran is often as the only clot-busting medication is used. The purpose of using streptokinase medication is to revive the ischemic heart tissue, although has dangerous complications too. Therefore, the present study aimed to determine the effect of streptokinase on reperfusion after acute myocardial infarction and its complications, has been designed and conducted.

MATERIALS & METHODS: This is an Ex-post facto study. The study population included patients who suffer from acute myocardial infarction. The sample size was 300 patients, and 2 groups were matched, in variables of age, sex, underlying disease, frequencies and area of MI. Data collection did by researcher making questionnaire, that accept face and content validity by 10 expert researcher, the reliability was conducted with Spearman's test (r=0.85) by Test-retest method. Data analysis did by SPSS software: V 12.

FINDINGS

Mean of EF in SK group was (46.15±8.11) and in control group was (43.11±12.57). Significant relationship was seen between SK, arrhythmia occurring and improve EF reperfusion by chi-square test (p=0.028), (p=0.020).The most arrhythmia in SK group was Ventricular Tachycardia (20.7%). Significant statistical relation between SK and mortality were found by Chi-square test (p=0.001). But a meaningful statistical relation was not found between SK and pulmonary edema incidence (p=0.071).

CONCLUSIONS

Nurses of CCU should be aware about SK complications such as hypotension, bleeding and arrhythmias. Proposed compare SK and tissue plasminogen drug in reperfusion and complications effect.

摘要

引言

急性心肌梗死患者的急诊治疗非常重要。在伊朗,链激酶常作为唯一的溶栓药物使用。使用链激酶药物的目的是使缺血的心脏组织恢复活力,不过它也有危险的并发症。因此,本研究旨在确定链激酶对急性心肌梗死后再灌注及其并发症的影响,并已进行设计和实施。

材料与方法

这是一项事后回顾性研究。研究人群包括急性心肌梗死患者。样本量为300例患者,两组在年龄、性别、基础疾病、心肌梗死的频率和面积等变量上进行了匹配。数据收集由研究人员编制问卷进行,该问卷经10位专家研究人员进行了表面效度和内容效度评估,通过重测法用Spearman检验(r = 0.85)进行了信度检验。数据分析使用SPSS软件:V 12。

研究结果

链激酶组的射血分数平均值为(46.15±8.11),对照组为(43.11±12.57)。通过卡方检验发现链激酶与心律失常的发生以及射血分数再灌注改善之间存在显著关系(p = 0.028),(p = 0.020)。链激酶组中最常见的心律失常是室性心动过速(20.7%)。通过卡方检验发现链激酶与死亡率之间存在显著的统计学关系(p = 0.001)。但未发现链激酶与肺水肿发生率之间有有意义的统计学关系(p = 0.071)。

结论

冠心病重症监护病房的护士应了解链激酶的并发症,如低血压、出血和心律失常。建议比较链激酶和组织纤溶酶原药物在再灌注及并发症影响方面的情况。

相似文献

4
Efficacy of a new accelerated streptokinase regime in acute myocardial infarction: a double blind randomized clinical trial.
Cardiovasc Ther. 2013 Feb;31(1):53-9. doi: 10.1111/j.1755-5922.2011.00284.x. Epub 2011 Aug 4.

引用本文的文献

1
Acute care for the three leading causes of mortality in lower-middle-income countries: A systematic review.
Int J Crit Illn Inj Sci. 2018 Jul-Sep;8(3):117-142. doi: 10.4103/IJCIIS.IJCIIS_22_18.

本文引用的文献

2
Heart disease and stroke statistics--2012 update: a report from the American Heart Association.
Circulation. 2012 Jan 3;125(1):e2-e220. doi: 10.1161/CIR.0b013e31823ac046. Epub 2011 Dec 15.
6
Accelerated streptokinase in ST-elevation myocardial infarction--a Romanian (ASK-ROMANIA) multicenter registry.
Int J Cardiol. 2007 Nov 30;122(3):216-23. doi: 10.1016/j.ijcard.2006.11.071. Epub 2007 Feb 6.
9
10
A comparison of the pharmacokinetic properties of streptokinase and anistreplase in acute myocardial infarction.
Br J Clin Pharmacol. 1991 Feb;31(2):143-7. doi: 10.1111/j.1365-2125.1991.tb05502.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验